King Christina D, Dudenhoeffer Joseph D, Gu Liqing, Evans Adam R, Robinson Renã A S
Department of Chemistry, University of Pittsburgh.
SGS North America Inc.
J Vis Exp. 2017 May 1(123):55406. doi: 10.3791/55406.
There is an increasing demand to analyze many biological samples for disease understanding and biomarker discovery. Quantitative proteomics strategies that allow simultaneous measurement of multiple samples have become widespread and greatly reduce experimental costs and times. Our laboratory developed a technique called combined precursor isotopic labeling and isobaric tagging (cPILOT), which enhances sample multiplexing of traditional isotopic labeling or isobaric tagging approaches. Global cPILOT can be applied to samples originating from cells, tissues, bodily fluids, or whole organisms and gives information on relative protein abundances across different sample conditions. cPILOT works by 1) using low pH buffer conditions to selectively dimethylate peptide N-termini and 2) using high pH buffer conditions to label primary amines of lysine residues with commercially-available isobaric reagents (see Table of Materials/Reagents). The degree of sample multiplexing available is dependent on the number of precursor labels used and the isobaric tagging reagent. Here, we present a 12-plex analysis using light and heavy dimethylation combined with six-plex isobaric reagents to analyze 12 samples from mouse tissues in a single analysis. Enhanced multiplexing is helpful for reducing experimental time and cost and more importantly, allowing comparison across many sample conditions (biological replicates, disease stage, drug treatments, genotypes, or longitudinal time-points) with less experimental bias and error. In this work, the global cPILOT approach is used to analyze brain, heart, and liver tissues across biological replicates from an Alzheimer's disease mouse model and wild-type controls. Global cPILOT can be applied to study other biological processes and adapted to increase sample multiplexing to greater than 20 samples.
为了深入了解疾病并发现生物标志物,对众多生物样本进行分析的需求日益增长。能够同时测量多个样本的定量蛋白质组学策略已广泛应用,极大地降低了实验成本和时间。我们实验室开发了一种名为组合前体同位素标记和等压标记(cPILOT)的技术,该技术增强了传统同位素标记或等压标记方法的样本复用能力。全局cPILOT可应用于源自细胞、组织、体液或整个生物体的样本,并能提供不同样本条件下相对蛋白质丰度的信息。cPILOT的工作原理是:1)使用低pH缓冲条件选择性地使肽N端二甲基化;2)使用高pH缓冲条件用市售等压试剂标记赖氨酸残基的伯胺(见材料/试剂表)。可用的样本复用程度取决于所使用的前体标签数量和等压标记试剂。在此,我们展示了一种12重分析方法,即结合轻、重二甲基化与六重等压试剂,在一次分析中对来自小鼠组织的12个样本进行分析。增强的复用能力有助于减少实验时间和成本,更重要的是,能够在较少的实验偏差和误差情况下,对许多样本条件(生物学重复、疾病阶段、药物治疗、基因型或纵向时间点)进行比较。在这项工作中,全局cPILOT方法被用于分析来自阿尔茨海默病小鼠模型和野生型对照的生物学重复样本中的脑、心脏和肝脏组织。全局cPILOT可应用于研究其他生物学过程,并可进行调整以将样本复用增加到20多个样本。